Volkmann contracture

Summary

Volkmann contracture (MONDO:0003528) is a disease. A subtype of skeletal muscle disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	Volkmann contracture
Mondo ID	MONDO:0003528
MeSH	D054061
DOID	DOID:5587
ICD-11	366740140
NCIT	C35130
SNOMED CT	111247001
UMLS	C0042951
MedGen	22684
GARD	0023549
Anatomy (UBERON)	UBERON:0002102
Is cancer (heuristic)	no

Also known as: Volkmann’s ischaemic contracture · Volkmann’s ischemic contracture

Disease family

This is a subtype of skeletal muscle disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › musculoskeletal system disorder › muscle tissue disorder › skeletal muscle disorder › Volkmann contracture

Related subtypes (12): anismus, skeletal muscle neoplasm, myopathy, diaphragm disorder, anterior compartment of tibia syndrome, rotator cuff syndrome, Cyprus facial-neuromusculoskeletal syndrome, Tel Hashomer camptodactyly syndrome, muscular dystrophy-white matter spongiosis syndrome, acquired skeletal muscle disease, myotonic syndrome, hereditary skeletal muscle disorder

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.